Consequently, on top of the beneficial effect of weight loss caused by GLP-1 analogues these drugs also cause a substantial reduction of the glycemic load (GL = carbohydrate intake X Glycemic index), which per se reduces hyperinsulinemia and causes weight loss [22], reduce diabetes risk [23], inflammation [24], and cardiovascular risk [25]
Gastrointestinal side effects of the non-peptide GLP-1 receptor agonists: A systematic review and meta-analysis
Evidence suggests that GLP-1RAs do not directly prevent gout attacks, but are effective in managing cardiometabolic conditions commonly associated with gout and other arthritides
The phone number on Mochis website connects you with customer service, who can answer questions regarding billing and shipping issues
Some studies also suggest functional selectivity, meaning these compounds activate certain signaling pathways more than others, which may explain differences in side-effect profiles
Common side effects include gastrointestinal symptoms (nausea, diarrhoea) with GLP-1 agonists and oily stools with orlistat